Skip to content
  • About
    • History of J-Star Research
      • Facilities
      • Chemical Information Library
    • Resources
    • Careers
      • Welcome to our Employment section
      • Diversity and Inclusion
      • CA Job Applicant Notice
      • CA Employee Notice
  • Contract R&D
    • Process Chemistry R&D
      • Synthetic Route Design
      • Catalysis & Enabling Technology
      • High-Throughput Experimentation (HTE)
      • High Pressure Chemistry Capabilities
      • Continuous Flow Capabilities
      • Statistics & Design of Experiments (DoE)
      • Computational Chemistry Capabilities
      • PAT & Reaction Kinetics
    • Analytical R&D and Quality Control
      • Method Development & Forced Degradation
      • Method Validation & Verification
      • Reference Standard Certification
      • Impurity Isolation & Structural Elucidation
      • Genotoxic Impurities
      • ICH Stability Studies
    • Center for Pharma Crystallization
      • Solid Form Screen & Studies
        • Single Crystal Structure Elucidation
      • Crystallization Process Development
      • Pre-Formulation Evaluations
      • Particle Engineering & Co-Processing
    • Drug Product Development
      • Phase 1 Clinical Supply and Support Services
      • Phase 2 & 3 Drug Product Development
      • Technology Demonstration & Feasibility
  • cGMP & Special Capabilities
    • cGMP Intermediate & API Production
      • cGMP Quality Assurance
      • Method Validation & Verification
      • Reference Standard Certification
      • ICH Stability Studies
      • Genotoxic Impurities
    • Special Capabilities
      • Controlled Substances (DEA Schedule II-V)
      • Potent & HPAPI Compound Development
  • News & Events
    • Company News
    • Tradeshows & Conferences
Contact
Contact
  • About
    • History of J-Star Research
      • Facilities
      • Chemical Information Library
    • Resources
    • Careers
      • Welcome to our Employment section
      • Diversity and Inclusion
      • CA Job Applicant Notice
      • CA Employee Notice
  • Contract R&D
    • Process Chemistry R&D
      • Synthetic Route Design
      • Catalysis & Enabling Technology
      • High-Throughput Experimentation (HTE)
      • High Pressure Chemistry Capabilities
      • Continuous Flow Capabilities
      • Statistics & Design of Experiments (DoE)
      • Computational Chemistry Capabilities
      • PAT & Reaction Kinetics
    • Analytical R&D and Quality Control
      • Method Development & Forced Degradation
      • Method Validation & Verification
      • Reference Standard Certification
      • Impurity Isolation & Structural Elucidation
      • Genotoxic Impurities
      • ICH Stability Studies
    • Center for Pharma Crystallization
      • Solid Form Screen & Studies
        • Single Crystal Structure Elucidation
      • Crystallization Process Development
      • Pre-Formulation Evaluations
      • Particle Engineering & Co-Processing
    • Drug Product Development
      • Phase 1 Clinical Supply and Support Services
      • Phase 2 & 3 Drug Product Development
      • Technology Demonstration & Feasibility
  • cGMP & Special Capabilities
    • cGMP Intermediate & API Production
      • cGMP Quality Assurance
      • Method Validation & Verification
      • Reference Standard Certification
      • ICH Stability Studies
      • Genotoxic Impurities
    • Special Capabilities
      • Controlled Substances (DEA Schedule II-V)
      • Potent & HPAPI Compound Development
  • News & Events
    • Company News
    • Tradeshows & Conferences

Novel Technology Platforms

Enabling Technology II. Dry Particle Coating for the Enhancement of Flowability and Bulk Density

By J-Star Research

Many active pharmaceutical ingredients (API) exhibit deficient bulk powder properties such as poor flowability, low bulk density, high cohesion, etc.

Enabling Technology II. Dry Particle Coating for the Enhancement of Flowability and Bulk Density Read More »

Enhance Powder Flow Density and Flow By Dry Particle Coating

By J-Star Research

Many active pharmaceutical ingredients (API) exhibit deficient bulk powder properties such as poor flowability, low bulk density, high cohesion, etc.

Enhance Powder Flow Density and Flow By Dry Particle Coating Read More »

J-STAR Research Inc., a subsidiary of Porton Pharma Solutions Ltd.

info@jstar-research.com

business@portonusa.com

3001 Hadley Road, Suites 1-5A
South Plainfield, NJ 07080

6 Cedarbrook Dr
Cranbury Township, NJ 08512

2 Clarke Dr
Cranbury Township, NJ 08512

Contract Research Organization (CRO): A trusted chemistry partner to leading pharmaceutical and biotechnology companies.
© 2024 J-STAR Research, Inc. All Rights Reserved - Privacy Policy | CA Residents: Do Not Sell or Share My Information